Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm

Journal of Neural Transmission

Volumn 118, Issue 6, 2011, Pages 925-943

  Wabbels, Bettina ^a   Jost, Wolfgang H ^b   Roggenkämper, Peter ^a  

^a UNIVERSITY OF BONN   (Germany)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

Blepharospasm; Blepharospasm disability index; Botulinum toxin; Dystonia; Jankovic rating scale

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; MEDITOXIN; PLACEBO; UNCLASSIFIED DRUG;

BLEPHAROSPASM; CLINICAL ASSESSMENT; DAILY LIFE ACTIVITY; DISABILITY; DRUG EFFICACY; ELSTON FUNCTIONAL STATUS SCALE; EYELID CLOSURE; FAHN RATING SCALE; FUNCTIONAL ASSESSMENT; HUMAN; MUSCLE SPASM; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; RATING SCALE; REVIEW;

BLEPHAROSPASM; BOTULINUM TOXINS, TYPE A; CLINICAL TRIALS AS TOPIC; DIAGNOSIS, DIFFERENTIAL; ENDPOINT DETERMINATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); SEVERITY OF ILLNESS INDEX;

EID: 80051669499     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0546-9     Document Type: Review

References (39)

1. Aramideh M, Ongerboer de Visser BW, Devriese PP, Bour LJ, Speelman JD (1994) Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm. Brain 117(Pt 1):27-38
2. Boyle MH, McGwin G Jr, Flanagan CE, Vicinanzo MG, Long JA (2009) High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference? Ophthal Plast Reconstr Surg 25:81-84
3. Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C (2002) Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 347:395-400 (Pubitemid 34851831)
4. Brin M, Blitzer A, Herman S, Steward C (1994) Oromandibular dystonia: treatment of 96 cases with botulinum A. In: Jankovic J, Hallett M (eds) Therapy with botulinum toxin. Marcel Dekker, New York, pp 429-435
5. Brin MF, Jankovic J, Comella C, Blitzer A, Tsui JKC, Pullman SL (1995) Treatment of dystonia using botulinum toxin. In: Kurlan R (ed) Treatment of movement disorders. Lippincott Company, New York, pp 183-246
6. Casse G, Adenis JP, Sauvage JP, Robert PY (2008) Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection. Graefes Arch Clin Exp Ophthalmol 246:1307-1314
7. Casse G, Adenis JP, Sauvage JP, Robert PY (2009) Videonystagmography to assess eyelid dynamic disorders. Orbit 28:20-24
8. Cohen DA, Savino PJ, Stern MB, Hurtig HI (1986) Botulinum injection therapy for blepharospasm: a review and report of 75 patients. Clin Neuropharmacol 9:415-429 (Pubitemid 17196757)
9. Elston JS (1992) The management of blepharospasm and hemifacial spasm. J Neurol 239:5-8
10. Elston JS, Russell RW (1985) Effect of treatment with botulinum toxin on neurogenic blepharospasm. Br Med J (Clin Res Ed) 290:1857-1859 (Pubitemid 15062842)
11. Fahn S (1985) Rating scales for blepharopsasm. In: Bosniak SL (ed) Blepharopsasm, advanced ophthalmology plastic reconstructive surgery. Pergamom Press, New York, pp 97-101
12. Fahn S, List T, Moskowitz C, Brin M, Bressman S, Burke RE, Scott A (1985) Double-blind controlled study of botulinum toxin for blepharospasm. Neurology 35(Suppl 1):271-272
13. Frueh BR, Nelson CC, Kapustiak JF, Musch DC (1988) The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment. Am J Ophthalmol 106:45-47
14. Girlanda P, Quartarone A, Sinicropi S, Nicolosi C, Messina C (1996) Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study. Mov Disord 11:27-31 (Pubitemid 26008560)
15. Goertelmeyer S, Brinkmann G, Comes A, Delcker A (2002) The Blepharospasm Disability Index (BSDI) for the assessment of functional health in focal dystonia. Clin Neurophysiol 113:S77-S78
16. Grandas F, Elston J, Quinn N, Marsden CD (1988) Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 51:767-772
17. Hallett M (2002) Blepharospasm: recent advances. Neurology 59:1306-1312 (Pubitemid 35285978)
18. Jankovic J, Orman J (1987) Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 37:616-623 (Pubitemid 17057937)
19. Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G (2009) Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord 24:407-413
20. Lindeboom R, De Haan R, Aramideh M, Speelman JD (1995) The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm. Mov Disord 10:444-449
21. Mauriello JA Jr, Dhillon S, Leone T, Pakeman B, Mostafavi R, Yepez MC (1996) Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years. Br J Ophthalmol 80:1073-1076 (Pubitemid 27010843)
22. Mezaki T, Kaji R, Brin MF, Hirota-Katayama M, Kubori T, Shimizu T, Kimura J (1999) Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial. Mov Disord 14:1017-1020
23. Müller J, Wissel J, Kemmler G, Voller B, Bodner T, Schneider A, Wenning GK, Poewe W (2004) Craniocervical dystonia questionnaire (CDQ-24): development and validation of a diseasespecific quality of life instrument. J Neurol Neurosurg Psychiatry 75:749-753 (Pubitemid 38526688)
24. Naumann M, Lowe NJ (2001) Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ 323:596-599 (Pubitemid 32846124)
25. Nussgens Z, Roggenkamper P (1995) Long-term treatment of blepharospasm with botulinum toxin type A. Ger J Ophthalmol 4:363-367
26. Nussgens Z, Roggenkämper P (1997) Comparison of two botulinum toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol 235:197-199 (Pubitemid 27326086)
27. Price J, Farish S, Taylor H, O'Day J (1997) Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections. Ophthalmology 104:865-868 (Pubitemid 27200888)
28. Quagliato EM, Carelli EF, Viana MA (2010) Prospective, randomized, double-blind study, comparing botulinum toxins type A Botox and Prosigne for blepharospasm and hemifacial spasm treatment. Clin Neuropharmacol 33:27-31
29. Rahman R, Berry-Brincat A, Thaller VT (2003) A new grading system for assessing orbicularis muscle function. Eye 17:610-612 (Pubitemid 36927103)
30. Rieder CR, Schestatsky P, Socal MP, Monte TL, Fricke D, Costa J, Picon PD (2007) A double-blind, randomized, crossover study of Prosigne versus Botox in patients with blepharospasm and hemifacial spasm. Clin Neuropharmacol 30:39-42 (Pubitemid 46204316)
31. Roggenkämper P, Jost WH, Bihari K, Comes G, Grafe S (2006) Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm 113:303-312 (Pubitemid 43201097)
32. Sampaio C, Ferreira JJ, Simoes F, Rosas MJ, Magalhaes M, Correia AP, Bastos-Lima A, Martins R, Castro-Caldas A (1997) DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-Dysport and Botox-assuming a ratio of 4:1. Mov Disord 12:1013-1018 (Pubitemid 27496782)
33. Scott AB, Kennedy RA, Stubbs HA (1985) Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 103:347-350 (Pubitemid 15137027)
34. Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan EP (1996) Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 46:1306-1310 (Pubitemid 26159292)
35. Truong D, Comella C, Fernandez HH, Ondo WG (2008) Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial. Parkinsonism Relat Disord 14:407-414
36. Tsoy EA, Buckley EG, Dutton JJ (1985) Treatment of blepharospasm with botulinum toxin. Am J Ophthalmol 99:176-179 (Pubitemid 15119578)
37. Wabbels B, Reichel G, Fulford-Smith A, Wright N, Roggenkämper P (2010) Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm. J Neural Transm. [Epub ahead of print] PMID: 21161715
38. Wissel J, Muller J, Dressnandt J, Heinen F, Naumann M, Topka H, Poewe W (2000) Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manag 20:44-49 (Pubitemid 30628581)
39. Yoon JS, Kim JC, Lee SY (2009) Double-blind, randomized, comparative study of Meditoxin versus Botox in the treatment of essential blepharospasm. Korean J Ophthalmol 23:137-141